CAT and metabolic dysfunction-associated steatohepatitis: Contrarily, Sreekumar et al. reported significantly downregulated CAT mRNA expression in the liver of patients with cirrhosis secondary to MASH (Sreekumar et al. 2003); while, conversely, no changes were observed in conventional MASH patients as compared to controls (Nagaya et al. 2015).